# Mid Atlantic Angel Fund

> Mid Atlantic Angel Fund is a VC fund in Philadelphia backing Software and CRM. See 4 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Philadelphia, United States
- Total investments: 4
- Last investment: Mar 2013
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.themagfundfunds.com

Mid Atlantic Angel Fund is a private equity firm that provides investments to firms based in New Jersey, Delaware, New York, and Maryland. It was founded by Chris Starr and is based in Pennsylvania.

## Contacts

5 contacts available for Mid Atlantic Angel Fund. Shizune tracks 2 team members at Mid Atlantic Angel Fund. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/mid-atlantic-angel-fund?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 2 | 50% |
| CRM | 1 | 25% |
| VoIP | 1 | 25% |
| Internet | 1 | 25% |
| Security | 1 | 25% |

15 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 50% |
| Series E | 1 | 25% |
| Funding Round | 1 | 25% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Chris Starr | Founder and Executive Director | 0 | https://shizune.co/investors/profile/chris-starr-2 |
| Jeff Snellenburg | Executive Director | 0 | https://shizune.co/investors/profile/jeff-snellenburg |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Novira Therapeutics | Novira Therapeutics is an antiviral drug discovery company that is focused on the discovery of first-in-class antiviral therapeutics for the treatment of chronic HBV and HIV infections, two global diseases with high levels of unmet need. Novira’s oral drugs target the capsid of the virus, and offer a promising treatment option both as monotherapyand in combination with current standards of care. The company’s antivirals potentially address limitations in treating chronic HBV infection, a disease for which the only class of oral drugs available, polymerase inhibitors, are rarely curative and often require lifelong treatment, as well as in chronic HIV infection, a disease for which the continued ability of the virus to mutate inevitably leads to drug-resistant viral strains. Each of these limitations to the standard of care can potentially be addressed by capsid inhibitors which feature a new mechanism of action. | $25M | Series A | Mar 24, 2013 |  |
| NanoPack | NanoPack is a materials science company, formed in 2004, that develops and markets cost-effective, environmentally friendly barrier materials for the packaging industry. Their products include both liquid coating to create barrier and the barrier coated films themselves. | $1.1M |  | Nov 24, 2008 |  |
| Preclick | Preclick is a media asset management software company founded to provide digital photographers the fastest, easiest and most convenient way to organize, print, preserve and share their digital photos.Preclick builds software for major corporations such as Hewlett-Packard, Wal-Mart, 3M, SanDisk, Costco and many online photofinishers includingPhotoWorks, dotPhoto and Adorama. Preclick has collaborated with HP in building HP Photosmart Essential (formerly HP Image Zone Express), the free software that makes it extremely easy to print your photos at home or to effortlessly share them online with your friends and family. The company was founded in 2001 and is headquartered in Atlantic Highlands, New Jersey. As of September 1, 2009, Preclick Corporation operates as a subsidiary of Smilebox, Inc. | $1.6M | Series A | Feb 20, 2007 |  |
| SentitO Networks | sentitO Networks is a leading provider of open and distributed VoIP switching and service delivery solutions that help telecommunications service providers worldwide successfully migrate their networks to deliver Voice over IP (VoIP) services. sentitO has fundamentally redesigned the time-to-profitability for VoIP service providers usingbreakthrough software, silicon, security, and service intelligence innovations. Our Open Network Xchange (ONX) suite of voice and signaling gateway solutions is the first to successfully fulfill the demands of VoIP providers for:- Network and service scalability- Heightened voice quality and integrity- Carrier-grade reliability- An open service delivery architecture that enables consistent innovation and differentiationThe first solution purpose-built from the ground up for VoIP and the resilient delivery of IP-based voice services from the network edge, the ONX allows carriers and service providers to economically expand their geographic reach and their addressable markets. It provides an open and distributed architecture to enable service providers to efficiently create and evolve VoIP services. The ONX suite incorporates true telco-grade security, management, and performance as well as SIP-driven service innovation and flexibility. Its modularity, scale, and economics uniquely enable rapid deployment and profitability while supporting ongoing service and subscriber expansion. | $6M | Series E | Aug 03, 2006 |  |

4 of 4 investments shown.

## Co-investors
- [Robin Hood Ventures](https://shizune.co/investors/profile/robin-hood-ventures) — VC Fund, 3 deals together
- [Delaware Crossing Investor Group](https://shizune.co/investors/profile/delaware-crossing-investor-group) — VC Fund, 2 deals together
- [LORE Associates](https://shizune.co/investors/profile/lore-associates) — VC Fund, 2 deals together
- [5AM Ventures](https://shizune.co/investors/profile/5am-ventures) — VC Fund, 1 deal together
- [BioAdvance](https://shizune.co/investors/profile/bioadvance) — VC Fund, 1 deal together
- [Canaan Partners](https://shizune.co/investors/profile/canaan-partners) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Mid Atlantic Angel Fund invest in?

Mid Atlantic Angel Fund invests primarily in Software, CRM and VoIP startups, most often at Series A and Series E stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Mid Atlantic Angel Fund?

Public channels for Mid Atlantic Angel Fund include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Mid Atlantic Angel Fund?

The team at Mid Atlantic Angel Fund includes Chris Starr (Founder and Executive Director) and Jeff Snellenburg (Executive Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co